| Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer E Tran, S Turcotte, A Gros, PF Robbins, YC Lu, ME Dudley, ... Science 344 (6184), 641-645, 2014 | 2413 | 2014 |
| Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy RA Morgan, N Chinnasamy, D Abate-Daga, A Gros, PF Robbins, Z Zheng, ... Journal of immunotherapy 36 (2), 133-151, 2013 | 1279 | 2013 |
| PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors A Gros, PF Robbins, X Yao, YF Li, S Turcotte, E Tran, JR Wunderlich, ... The Journal of clinical investigation 124 (5), 2246-2259, 2014 | 1085 | 2014 |
| Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients A Gros, MR Parkhurst, E Tran, A Pasetto, PF Robbins, S Ilyas, TD Prickett, ... Nature medicine 22 (4), 433-438, 2016 | 847 | 2016 |
| Immunogenicity of somatic mutations in human gastrointestinal cancers E Tran, M Ahmadzadeh, YC Lu, A Gros, S Turcotte, PF Robbins, ... Science 350 (6266), 1387-1390, 2015 | 747 | 2015 |
| Ionic immune suppression within the tumour microenvironment limits T cell effector function R Eil, SK Vodnala, D Clever, CA Klebanoff, M Sukumar, JH Pan, ... Nature 537 (7621), 539-543, 2016 | 538 | 2016 |
| Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics JG Crompton, M Sukumar, R Roychoudhuri, D Clever, A Gros, RL Eil, ... Cancer research 75 (2), 296-305, 2015 | 348 | 2015 |
| Memory T cell–driven differentiation of naive cells impairs adoptive immunotherapy CA Klebanoff, CD Scott, AJ Leonardi, TN Yamamoto, AC Cruz, C Ouyang, ... The Journal of clinical investigation 126 (1), 318-334, 2016 | 247 | 2016 |
| Hyaluronidase expression by an oncolytic adenovirus enhances its intratumoral spread and suppresses tumor growth S Guedan, JJ Rojas, A Gros, E Mercade, M Cascallo, R Alemany Molecular Therapy 18 (7), 1275-1283, 2010 | 229 | 2010 |
| Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapy R Yossef, E Tran, DC Deniger, A Gros, A Pasetto, MR Parkhurst, ... JCI insight 3 (19), 2018 | 202 | 2018 |
| Tumor-and neoantigen-reactive T-cell receptors can be identified based on their frequency in fresh tumor A Pasetto, A Gros, PF Robbins, DC Deniger, TD Prickett, ... Cancer immunology research 4 (9), 734-743, 2016 | 189 | 2016 |
| Targeting of HPV-16+ epithelial cancer cells by TCR gene engineered T cells directed against E6 LM Draper, MLM Kwong, A Gros, S Stevanović, E Tran, S Kerkar, ... Clinical Cancer Research 21 (19), 4431-4439, 2015 | 182 | 2015 |
| Isolation of T-cell receptors specifically reactive with mutated tumor-associated antigens from tumor-infiltrating lymphocytes based on CD137 expression M Parkhurst, A Gros, A Pasetto, T Prickett, JS Crystal, P Robbins, ... Clinical cancer research 23 (10), 2491-2505, 2017 | 176 | 2017 |
| Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor AntigensAdoptive Transfer of TILs Seeing 10 Mutated Tumor … TD Prickett, JS Crystal, CJ Cohen, A Pasetto, MR Parkhurst, JJ Gartner, ... Cancer immunology research 4 (8), 669-678, 2016 | 145 | 2016 |
| The expanding role of immunotherapy J Martin-Liberal, MO de Olza, C Hierro, A Gros, J Rodon, J Tabernero Cancer treatment reviews 54, 74-86, 2017 | 136 | 2017 |
| Determinants for neoantigen identification A Garcia-Garijo, CA Fajardo, A Gros Frontiers in immunology 10, 463589, 2019 | 133 | 2019 |
| Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytes A Gros, E Tran, MR Parkhurst, S Ilyas, A Pasetto, EM Groh, PF Robbins, ... The Journal of clinical investigation 129 (11), 4992-5004, 2019 | 127 | 2019 |
| Phenotype and function of T cells infiltrating visceral metastases from gastrointestinal cancers and melanoma: implications for adoptive cell transfer therapy S Turcotte, A Gros, K Hogan, E Tran, CS Hinrichs, JR Wunderlich, ... The Journal of Immunology 191 (5), 2217-2225, 2013 | 120 | 2013 |
| Myeloid cells obtained from the blood but not from the tumor can suppress T-cell proliferation in patients with melanoma A Gros, S Turcotte, JR Wunderlich, M Ahmadzadeh, ME Dudley, ... Clinical Cancer Research 18 (19), 5212-5223, 2012 | 117 | 2012 |
| Intratumor adoptive transfer of IL-12 mRNA transiently engineered antitumor CD8+ T cells I Etxeberria, E Bolaņos, JI Quetglas, A Gros, A Villanueva, J Palomero, ... Cancer Cell 36 (6), 613-629. e7, 2019 | 109 | 2019 |
Steven A RosenbergNCIVerified email at nih.gov
